Stock CERS CERUS CORPORATION
Add to a list
To use this feature you must be a member
Log inSign up

Consensus Cerus Corporation

Equities

CERS

US1570851014

Market Closed - Nasdaq
Other stock markets
 21:00:00 26/04/2024 BST 		5-day change 1st Jan Change
1.71 USD +0.59% Intraday chart for Cerus Corporation +1.79% -20.83%
04-12 Craig-Hallum Starts Cerus With Buy Rating, $5 Price Target MT
03-26 Cerus Corporation Announces FDA Approval of Extended Shelf Life for INTERCEPT Platelet Processing Sets - Doubling Previous Shelf Life CI

Evolution of the average Target Price on Cerus Corporation

Price target over the last 5 years

History of analyst recommendation changes

7716b0643033e519111c70c8d.eBaIB7y_1ZHCn7F0iYtrJ6LDw5dKqmlczCCerIbhIC8.FjuwMOj6rOKL99Qk3MhfXuqOh6E8hzhs_2PX2LO0VnsUXuM00PChxaWv8A~bd6399dd7147b099b0f0243ef7a1cea6

Analyst Recommendations on Cerus Corporation

Craig-Hallum Starts Cerus With Buy Rating, $5 Price Target MT
BTIG Downgrades Cerus to Neutral From Buy MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
6
Last Close Price
1.71 USD
Average target price
4.2 USD
Spread / Average Target
+145.61%
High Price Target
6 USD
Spread / Highest target
+250.88%
Low Price Target
2 USD
Spread / Lowest Target
+16.96%

Consensus detail

Consensus revision (last 18 months)

Analysts covering Cerus Corporation

Craig-Hallum
BTIG

Ratings for Cerus Corporation

Trading Rating
Investor Rating
ESG Refinitiv
C
More Ratings

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. CERS Stock
  4. Consensus Cerus Corporation